Markray Corp. Announces Quantum-Leap Breakthrough in Science and Technology by Converting Energy to Matter and Gas Using Edge of Science Cosmic Ray Technology
Notified -
Globe Newswire6-11-2025, 04:09
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26